These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29082244)

  • 1. Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.
    Re M; Magliulo G; Gioacchini FM; Bajraktari A; Bertini A; Çeka A; Rubini C; Ferrante L; Procopio AD; Olivieri F
    Biomed Res Int; 2017; 2017():3921258. PubMed ID: 29082244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma.
    Re M; Çeka A; Rubini C; Ferrante L; Zizzi A; Gioacchini FM; Tulli M; Spazzafumo L; Sellari-Franceschini S; Procopio AD; Olivieri F
    Laryngoscope; 2015 Sep; 125(9):E306-12. PubMed ID: 26153151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of miR-20b-5p indicates favorable prognosis in laryngeal squamous cell carcinoma, especially in patients with non-infiltrated regional lymph nodes.
    Pantazis TL; Giotakis AI; Karamagkiolas S; Giotakis I; Konstantoulakis M; Liakea A; Misiakos EP
    Am J Otolaryngol; 2020; 41(5):102563. PubMed ID: 32521298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
    Fang R; Huang Y; Xie J; Zhang J; Ji X
    Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma.
    Maia D; de Carvalho AC; Horst MA; Carvalho AL; Scapulatempo-Neto C; Vettore AL
    J Transl Med; 2015 Aug; 13():262. PubMed ID: 26264462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of targeted inhibition of HMGA2 via miRNAlet-7a in proliferation and metastasis of laryngeal squamous cell carcinoma.
    Ma LJ; Wu J; Zhou E; Yin J; Xiao XP
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32432318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
    Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
    Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis.
    Wang Z; Huang C; Zhang A; Lu C; Liu L
    Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
    Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
    Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
    Hui L; Zhang J; Guo X
    Biomed Pharmacother; 2018 Jul; 103():1194-1201. PubMed ID: 29864898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer.
    Long XB; Sun GB; Hu S; Liang GT; Wang N; Zhang XH; Cao PP; Zhen HT; Cui YH; Liu Z
    Oncol Rep; 2009 Nov; 22(5):1189-95. PubMed ID: 19787239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma.
    Li P; Lin XJ; Yang Y; Yang AK; Di JM; Jiang QW; Huang JR; Yuan ML; Xing ZH; Wei MN; Li Y; Yuan XH; Shi Z; Liu H; Ye J
    Cell Death Dis; 2019 Dec; 10(12):916. PubMed ID: 31801947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
    Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
    Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA profile in site-specific head and neck squamous cell cancer.
    Kalfert D; Pesta M; Kulda V; Topolcan O; Ryska A; Celakovsky P; Laco J; Ludvikova M
    Anticancer Res; 2015 Apr; 35(4):2455-63. PubMed ID: 25862914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma.
    Zhao X; Zhang W; Ji W
    Future Oncol; 2018 Jul; 14(17):1741-1753. PubMed ID: 29517349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).
    Lucas Grzelczyk W; Szemraj J; Kwiatkowska S; Józefowicz-Korczyńska M
    Diagn Pathol; 2019 May; 14(1):49. PubMed ID: 31138255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.
    Lapa RML; Barros-Filho MC; Marchi FA; Domingues MAC; de Carvalho GB; Drigo SA; Kowalski LP; Rogatto SR
    Oral Oncol; 2019 Jun; 93():76-84. PubMed ID: 31109699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma.
    Xue L; Nan J; Dong L; Zhang C; Li H; Na R; He H; Wang Y
    Cancer Biomark; 2017; 19(2):193-197. PubMed ID: 28211800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.